Trials / Conditions / MF
MF
6 registered clinical trials studyying MF — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolera NCT07443306 | Chengdu Zenitar Biomedical Technology Co., Ltd | Phase 2 |
| Recruiting | A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis NCT07317700 | Chengdu Zenitar Biomedical Technology Co., Ltd | Phase 3 |
| Recruiting | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People NCT07362225 | MPN Research Foundation | — |
| Recruiting | Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Subop NCT06479135 | Kartos Therapeutics, Inc. | Phase 3 |
| Recruiting | A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682 | Jacobio Pharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |
| Withdrawn | Ruxolitinib in Combination With Autotransplant NCT02469974 | Marina Kremyanskaya | N/A |